Tech Company Financing Transactions
Esprit Pharma Funding Round
Esprit Pharma secured a $90 million Series B funding round on 8/2/2006. Investors included Apax Partners, Domain Associates and Greenspring Global Partners.
Transaction Overview
Company Name
Announced On
8/2/2006
Transaction Type
Venture Equity
Amount
$90,000,000
Round
Series B
Investors
Proceeds Purpose
This financing improves the financial health and prospects of Esprit to further drive growth and stay on course with our commitment to achieving pre-eminence in the urology and women's health care specialty markets.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
2 Tower Center Boulevard
East Brunswick, NJ 08816
USA
East Brunswick, NJ 08816
USA
Phone
Website
Email Address
Not Recorded
Overview
Esprit Pharma is a privately held, niche-oriented pharmaceutical company located in East Brunswick, NJ, committed to improving patient outcomes and well-being within the urology and women's healthcare fields.
Management Team
Browse more venture capital transactions:
Prev: 8/2/2006: Biodel venture capital transaction
Next: 8/2/2006: Acceleron Pharma venture capital transaction
Share this article
News on VC Transactions
We do our best to report on every notable VC transaction. VC investment data records on this site are sourced from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs